BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borgini M, Mondal P, Liu R, Wipf P. Chemical modulation of Kv7 potassium channels. RSC Med Chem 2021;12:483-537. [PMID: 34046626 DOI: 10.1039/d0md00328j] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Cooper B, Nutter T, Flunker L, Bowers C. Combinations of classical and non-classical voltage dependent potassium channel openers suppress nociceptor discharge and reverse chronic pain signs in a rat model of Gulf War illness. NeuroToxicology 2022;93:186-199. [DOI: 10.1016/j.neuro.2022.10.003] [Reference Citation Analysis]
2 Wurm KW, Bartz F, Schulig L, Bodtke A, Bednarski PJ, Link A. Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K V 7 channel openers: Exploration of a nicotinamide scaffold. Archiv der Pharmazie 2022. [DOI: 10.1002/ardp.202200473] [Reference Citation Analysis]
3 Zhan X, Drummond-Main C, Greening D, Yao J, Chen SWR, Appendino JP, Au PYB, Turner RW. Cannabidiol counters the effects of a dominant-negative pathogenic Kv7.2 variant. iScience 2022;25:105092. [PMID: 36157585 DOI: 10.1016/j.isci.2022.105092] [Reference Citation Analysis]
4 Bauer CK, Holling T, Horn D, Laço MN, Abdalla E, Omar OM, Alawi M, Kutsche K. Clinically Relevant KCNQ1 Variants Causing KCNQ1-KCNE2 Gain-of-Function Affect the Ca2+ Sensitivity of the Channel. IJMS 2022;23:9690. [DOI: 10.3390/ijms23179690] [Reference Citation Analysis]
5 Naznin F, Waise TMZ, Fernyhough P. Antagonism of the Muscarinic Acetylcholine Type 1 Receptor Enhances Mitochondrial Membrane Potential and Expression of Respiratory Chain Components via AMPK in Human Neuroblastoma SH-SY5Y Cells and Primary Neurons. Mol Neurobiol 2022. [PMID: 36002781 DOI: 10.1007/s12035-022-03003-1] [Reference Citation Analysis]
6 Peixoto Pinheiro B, Müller M, Bös M, Guezguez J, Burnet M, Tornincasa M, Rizzetto R, Rolland J, Liberati C, Lohmer S, Adel Y, Löwenheim H. A potassium channel agonist protects hearing function and promotes outer hair cell survival in a mouse model for age-related hearing loss. Cell Death Dis 2022;13:595. [DOI: 10.1038/s41419-022-04915-5] [Reference Citation Analysis]
7 Singh SP, William M, Malavia M, Chu X. Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders. Membranes 2022;12:499. [DOI: 10.3390/membranes12050499] [Reference Citation Analysis]
8 Hotta N, Miyamoto M, Suzuki K. Lamotrigine and retigabine increase motor threshold in transcranial magnetic stimulation at the dose required to produce an antiepileptic effect against maximal electroshock-induced seizure in rats. Neurosci Lett 2022;:136460. [PMID: 35051437 DOI: 10.1016/j.neulet.2022.136460] [Reference Citation Analysis]
9 Zhang X, Wang H, Wang Q. Progression of KCNQ4 related genetic hearing loss: a narrative review. Journal of Bio-X Research 2021;4:151-7. [DOI: 10.1097/jbr.0000000000000112] [Reference Citation Analysis]